Biocryst Pharmaceuticals Inc (BCRX)

Deferred Revenue

$12.32M

Quarterly · Period ending: · USD

BCRX logo

BCRX Deferred Revenue

Latest reported$12.32M
BCRX Quarterly Deferred Revenue ($0.00 → $12.32M)
High-resolution chart · PNG

BCRX deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
3,399,000
2,813,000
2,813,445,000
0
100,000
581,504
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.